EMA Authorised: Dasselta (desloratadine) — Krka, d.d., Novo mesto

View source ↗

Summary

Dasselta (desloratadine) by Krka has been authorised for allergic rhinitis (perennial and seasonal) and urticaria in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Dasselta (desloratadine)

Snippet

Status: Authorised. Therapeutic area: Rhinitis, Allergic, Perennial;Rhinitis, Allergic, Seasonal;Urticaria. MAH: Krka, d.d., Novo mesto. Decision date: 04/06/2026